Surgical laser devices generate laser beams of specific wavelengths that is used during surgical procedures for tissue cutting, destruction, or clotting. These lasers find applications in the fields of ophthalmology, dermatology, gynecology, cardiology, and urology, among others. Moreover, carbon dioxide lasers, argon lasers, and diode lasers are the types of surgical lasers commonly used in the healthcare industry.
North America and Europe are major contributors to the growth of the surgical lasers market due to the rising prevalence of chronic diseases and the technological advancements in these regions.
The Asia-Pacific region is expected to be the new revenue-generating market for players engaged in offering surgical laser products. Rising awareness among healthcare professionals related to the procedural benefits of surgical laser products, increasing government initiatives to reduce the burden of ophthalmic disorders, ongoing government initiatives to modernize & expand healthcare infrastructure, continuous reduction in product prices (owing to an increase in domestic manufacturing and strengthening of distribution networks by prominent device manufacturers), and growing trend of medical tourism are expected to drive the growth of surgical lasers in the Asia-Pacific region.
On the basis of type, the market is categorized into five segments, namely, Carbon dioxide (CO2) lasers, argon lasers, Nd:YAG lasers, diode lasers, and other surgical lasers (fiber lasers, dye lasers, Er:YAG lasers, and excimer lasers). The Carbon dioxide (CO2) lasers segment is at the highest CAGR in the market due to the widespread availability of innovative CO2-based surgical lasers and ongoing technological advancements in cosmetic laser treatment.
Based on procedure type, the market is segmented into open surgery, laparoscopic surgery, and percutaneous surgery. The laparoscopic surgery segment is expected to dominate the market during the forecast period. This growth can be primarily attributed to the procedural benefits of laparoscopic procedures, growing patient awareness, and market demand for less-invasive disease therapies.
By application, the market is segmented into ophthalmology, dentistry, dermatology, cardiology, gynecology, urology, oncology, and other applications (liposuction, ENT, and GIT). The urology segment is expected to be the fastest-growing surgical laser application. Growth in this application segment is mainly due to the rising prevalence of urological disorders (such as kidney stones, renal cancer, and prostate enlargement), growing patient preference for minimally invasive urological surgeries, and ongoing technological advancements in surgical laser products.